Effect of the therapeutic effect of chromium supplementation with doses of 400 and 600 micrograms on body mass index

Phase 3

Recruiting

• Conditions: Polycystic ovarian syndrome.; Polycystic ovarian syndrome; E28.2

• Registration Number: IRCT20210515051298N1
• Lead Sponsor: Shahre-kord University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 August 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 120

Inclusion Criteria

Satisfaction of patients aged 16 to 40 years
Polycystic Ovary Syndrome

Exclusion Criteria

Take chromium picolinate supplement regularlyHydroxy
Progesterone above 2

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Body mass index. Timepoint: Two months after the start of the intervention. Method of measurement: Questionaire.;Insulin sensitivity. Timepoint: Two months after the start of the intervention. Method of measurement: Questionaire.;Depression. Timepoint: Two months after the start of the intervention. Method of measurement: Questionaire.